Amphotericin B deoxycholate: no significant advantage of a 24 h over a 6 h infusion schedule

被引：8
作者：
Altmannsberger, Philipp [1 ]
Holler, Ernst [1 ]
Andreesen, Reinhard [1 ]
Krause, Stefan W. [1 ]
机构：
[1] Univ Hosp, Dept Haematol & Oncol, D-93042 Regensburg, Germany
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2007年 / 60卷 / 01期
关键词：
D O I：
10.1093/jac/dkm147
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：180 / 182
页数：3
相关论文
共 6 条
  • [1] Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
    Ascioglu, S
    Rex, JH
    de Pauw, B
    Bennett, JE
    Bille, J
    Crokaert, F
    Denning, DW
    Donnelly, JP
    Edwards, JE
    Erjavec, Z
    Fiere, D
    Lortholary, O
    Maertens, J
    Meis, JF
    Patterson, TF
    Ritter, J
    Selleslag, D
    Shah, PM
    Stevens, DA
    Walsh, TJ
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) : 7 - 14
  • [2] Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial
    Eriksson, U
    Seifert, B
    Schaffner, A
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2001, 322 (7286): : 579 - 582
  • [3] Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysis (vol 24, pg 119, 2005)
    Girois, SB
    Chapuis, F
    Decullier, E
    Revol, BGP
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2006, 25 (02) : 138 - 149
  • [4] MASCHMEYER G, 1994, CANCER, V73, P2296, DOI 10.1002/1097-0142(19940501)73:9<2296::AID-CNCR2820730910>3.0.CO
  • [5] 2-7
  • [6] Continuous and 4h infusion of amphotericin B: a comparative study involving high-risk haematology patients
    Peleg, AY
    Woods, ML
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (04) : 803 - 808
1